Safety and efficacy of metabolic surgery in patients with viral hepatitis cirrhosis
10.3760/cma.j.cn113855-20220509-00303
- VernacularTitle:合并病毒性肝炎肝硬化患者代谢手术的安全性及疗效分析
- Author:
Zhong QI
1
;
Wenmao YAN
;
Rixing BAI
Author Information
1. 首都医科大学附属北京天坛医院普通外科，北京 100070
- Keywords:
Hepatitis,viral,human;
Cirrhosis;
Obesity;
Type 2 diabetes;
Metabolic surgery
- From:
Chinese Journal of General Surgery
2022;37(12):911-915
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the safety and efficacy of metabolic surgery in obese and type 2 diabetes patients with viral hepatitis cirrhosis.Methods:The data of 8 patients with viral hepatitis cirrhosis undergoing metabolic surgery at Department of General Surgery ,Beijing Tiantan Hospital, Capital Medical University from Aug 2012 to Dec 2021 were retrospectively analyzed.Results:Among the 8 patients, 2 underwent laparoscopic Roux-en-Y gastric bypass and 6 underwent laparoscopic sleeve gastrectomy. The Child-Pugh classification of all patients before operation was classified as Grade A. The operation process was successful with no complications such as ascites, bleeding , digestive tract and gastric leakage or obstruction during the perioperative period. There was no abnormal liver function and decompensation during the median 2.5 year's (3 month to 8 years) follow-up period. The weight loss after the operation was obvious, when 1 year after operation, percentage of excess weight loss (EWL%)>54.78% and the surgery was also conducive to the control of blood glucose in diabetes patients.Conclusion:Metabolic surgery is safe and feasible for obese and type 2 diabetes patients with viral hepatitis cirrhosis.
